ClinicalTrials.Veeva

Menu

Molecular Diagnosis of Syndromic or Isolated Severe Intellectual Disability Using Whole Exome Sequencing : a Pilot Study (SHD-DI)

C

Centre Hospitalier Universitaire de Besancon

Status

Completed

Conditions

Severe Intellectual Disability

Study type

Observational

Funder types

Other

Identifiers

NCT02862808
P/2015/242

Details and patient eligibility

About

Evaluation of diagnostic whole exome sequencing in patients with syndromic or isolated severe intellectual disability without a molecular diagnostic, with suspected autosomal recessive inheritance, allowing accurate genetic counseling in this high risk of recurrence group of diseases

Enrollment

18 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of syndromic or isolated severe intellectual disability (IQ <50) without a molecular diagnosis
  • Recurrence in siblings (multiplex families) suggesting autosomal recessive inheritance (with or without parental consanguinity) or sporadic cases from a consanguineous union
  • Conventional genetic tests performed (including array-CGH) and MRI/CT-scan available
  • DNA samples from parents and from both unaffected or affected siblings available, for parental segregation and confirmation of candidate variations identified.
  • Availability of a signed informed consent
  • To be affiliated or beneficiary of French social security/healthcare system

Exclusion criteria

  • Parents in the exclusion period of another study or as provided by the national register of volunteers
  • High-probability diagnostic hypothesis for which a molecular test is available at lower cost than exome sequencing

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems